KITADE Yukio | United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University
スポンサーリンク
概要
- KITADE Yukioの詳細を見る
- 同名の論文著者
- United Graduate School of Drug Discovery and Medical Information Sciences, Gifu Universityの論文著者
関連著者
-
KITADE Yukio
United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University
-
Kitade Yukio
United Graduate School Of Drug Discovery And Medical Information Sciences Gifu Univ.
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
AKAO Yukihiro
Department of Medical Oncology, Gifu International Institute of Biotechnology
-
NAKAGAWA Yoshihito
Department of Medical Oncology, Gifu International Institute of Biotechnology
-
Kitade Yukio
United Graduate School Of Drug Discovery And Medical Information Sciences Gifu University
-
Akao Yukihiro
Department Of Anatomy And Biology Osaka Medical College
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Kinoshita Tomohiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Nakagawa Yoshihito
Department Of Medical Oncology Gifu International Institute Of Biotechnology
-
Akao Yukihiro
United Graduate School of Drug Discovery and Medicinal Information Sciences, Gifu University, Japan
-
Araki Yoko
Nagaragawa Res. Center Api Co. Ltd.
-
Akao Yukihiro
United Graduate School Of Drug Discovery And Medicinal Information Sciences Gifu University
-
KINOSHITA Tomohiro
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University, Graduate School of Medicine
著作論文
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- MicroRNAs and Their Therapeutic Potential for Human Diseases: MicroRNAs, miR-143 and -145, Function as Anti-oncomirs and the Application of Chemically Modified miR-143 as an Anti-cancer Drug